StockNews.com initiated coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a report issued on Friday. The firm issued a sell rating on the stock. Cancer Genetics Trading Down 2.3 % Cancer Genetics stock opened at $4.61 on Friday. Cancer Genetics has a twelve month low of $2.11 and a twelve month high […]
StockNews.com initiated coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a research report report published on Wednesday. The firm issued a sell rating on the stock. Cancer Genetics Price Performance CGIX stock opened at $0.17 on Wednesday. Cancer Genetics has a fifty-two week low of $2.11 and a fifty-two week high of […]
StockNews.com initiated coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a research report released on Tuesday morning. The brokerage issued a sell rating on the stock. Cancer Genetics Trading Down 6.4 % Shares of Cancer Genetics stock opened at $0.17 on Tuesday. The stock has a market cap of $682,195.00, a price-to-earnings […]
Cancer Genetics (NASDAQ:CGIX – Get Free Report) is one of 49 publicly-traded companies in the “Medical Laboratories” industry, but how does it compare to its peers? We will compare Cancer Genetics to similar companies based on the strength of its analyst recommendations, dividends, valuation, risk, earnings, institutional ownership and profitability. Institutional and Insider Ownership 8.9% […]
Cancer Genetics (NASDAQ:CGIX – Get Free Report) is one of 48 publicly-traded companies in the “Medical Laboratories” industry, but how does it compare to its rivals? We will compare Cancer Genetics to related companies based on the strength of its profitability, earnings, analyst recommendations, valuation, dividends, risk and institutional ownership. Risk and Volatility Cancer Genetics […]